"Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
| Descriptor ID |
D001127
|
| MeSH Number(s) |
D06.472.699.631.692.781.100 D12.644.400.900.100 D12.644.456.925.100 D12.644.548.691.692.781.100 D12.776.631.650.937.100
|
| Concept/Terms |
Arginine Vasopressin- Arginine Vasopressin
- Argipressin
- Arg-Vasopressin
- Arg Vasopressin
- Vasopressin, Arginine
|
Below are MeSH descriptors whose meaning is more general than "Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Arginine Vasopressin".
This graph shows the total number of publications written about "Arginine Vasopressin" by people in this website by year, and whether "Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arginine Vasopressin" by people in Profiles.
-
Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect. Psychoneuroendocrinology. 2011 Oct; 36(9):1312-26.
-
Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology. 2010 Apr; 151(4):1795-805.
-
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation. 2001 Nov 13; 104(20):2417-23.
-
Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001 Oct; 281(4):H1545-52.
-
Vasopressin's depolarizing action on neonatal rat spinal lateral horn neurons may involve multiple conductances. Adv Exp Med Biol. 1998; 449:201-10.
-
Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. Am J Physiol. 1997 Aug; 273(2 Pt 2):H971-80.
-
The effects of intracerebroventricular versus intravenous administration of vasopressin on intracranial pressure in the rat. Neurol Res. 1993 Jun; 15(3):198-203.
-
Suppression of Ca2+ oscillations in cultured rat hepatocytes by chemical hypoxia. J Biol Chem. 1991 Oct 25; 266(30):20062-9.
-
Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin. Am J Physiol. 1987 Jul; 253(1 Pt 2):R136-41.
-
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab. 1983 Nov; 57(5):952-7.